Cargando…
LncRNA GClnc1 may contribute to the progression of ovarian cancer by regulating p53 signaling pathway
Ovarian cancer (OC) is one of the most prevalent and deadly types of gynecological malignancy. Since current treatments are not effective against OC, it is imperative to develop novel potential therapeutic targets for managing OC. In this study, we aimed to uncover the underlying molecular mechanism...
Autores principales: | Li, Hu, Zeng, Zheng, Yang, Xiang, Chen, Ye, He, Lei, Wan, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662106/ https://www.ncbi.nlm.nih.gov/pubmed/33207861 http://dx.doi.org/10.4081/ejh.2020.3166 |
Ejemplares similares
-
lncRNA ABHD11‐AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2
por: Zeng, Xiang‐Yang, et al.
Publicado: (2019) -
Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein
por: Liu, Mingliang, et al.
Publicado: (2019) -
LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway
por: Lin, Xueke, et al.
Publicado: (2020) -
LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression
por: Tao, Weiyang, et al.
Publicado: (2019) -
LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
por: Liu, Fang, et al.
Publicado: (2022)